OXA-48 Carbapenemase-Producing Enterobacterales in Spanish Hospitals: An Updated Comprehensive Review on a Rising Antimicrobial Resistance
出版年份 2021 全文链接
标题
OXA-48 Carbapenemase-Producing Enterobacterales in Spanish Hospitals: An Updated Comprehensive Review on a Rising Antimicrobial Resistance
作者
关键词
-
出版物
Antibiotics-Basel
Volume 10, Issue 1, Pages 89
出版商
MDPI AG
发表日期
2021-01-19
DOI
10.3390/antibiotics10010089
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Molecular Epidemiology of OXA-48 and NDM-1 Producing Enterobacterales Species at a University Hospital in Tehran, Iran, Between 2015 and 2016
- (2020) Hamid Solgi et al. Frontiers in Microbiology
- Emerging Antimicrobial Resistant High-Risk clones among Klebsiella pneumoniae: ST307 and ST147
- (2020) Gisele Peirano et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Sociodemographic, clinical and laboratory factors on admission associated with COVID-19 mortality in hospitalized patients: A retrospective observational study
- (2020) Mario Rivera-Izquierdo et al. PLoS One
- Clinical Factors, Preventive Behaviours and Temporal Outcomes Associated with COVID-19 Infection in Health Professionals at a Spanish Hospital
- (2020) Mario Rivera-Izquierdo et al. International Journal of Environmental Research and Public Health
- Prevalence of Multi-Resistant Microorganisms and Antibiotic Stewardship among Hospitalized Patients Living in Residential Care Homes in Spain: A Cross-Sectional Study
- (2020) Mario Rivera-Izquierdo et al. Antibiotics-Basel
- Intestinal loads of OXA-48-producing Klebsiella pneumoniae in colonized patients determined from surveillance rectal swabs
- (2020) Fernando Lázaro-Perona et al. CLINICAL MICROBIOLOGY AND INFECTION
- In vitro activity of eravacycline compared with tigecycline against carbapenem-resistant Enterobacteriaceae
- (2020) Justin A. Clark et al. INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS
- Efficacy of human-simulated exposures of meropenem/vaborbactam and meropenem against OXA-48 β-lactamase-producing Enterobacterales in the neutropenic murine thigh infection model
- (2020) Christian M Gill et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- Efficacy and safety of cefiderocol or best available therapy for the treatment of serious infections caused by carbapenem-resistant Gram-negative bacteria (CREDIBLE-CR): a randomised, open-label, multicentre, pathogen-focused, descriptive, phase 3 trial
- (2020) Matteo Bassetti et al. LANCET INFECTIOUS DISEASES
- Emergence and Persistence over Time of Carbapenemase-Producing Enterobacter Isolates in a Spanish University Hospital in Madrid, Spain (2005–2018)
- (2020) Miriam Mateos et al. Microbial Drug Resistance
- Comparative Kinetic Analysis of OXA-438 with Related OXA-48-Type Carbapenem-Hydrolyzing Class D β-Lactamases
- (2020) Denise De Belder et al. ACS Infectious Diseases
- Risk Factors for Carbapenemase-Producing Enterobacterales Infection or Colonization in a Korean Intensive Care Unit: A Case–Control Study
- (2020) Young Ah Kim et al. Antibiotics-Basel
- Antibiogram, Prevalence of OXA Carbapenemase Encoding Genes, and RAPD-Genotyping of Multidrug-Resistant Acinetobacter baumannii Incriminated in Hidden Community-Acquired Infections
- (2020) Waleed El-Kazzaz et al. Antibiotics-Basel
- Molecular Epidemiology of Carbapenemases in Enterobacteriales from Humans, Animals, Food and the Environment
- (2020) Gurleen Taggar et al. Antibiotics-Basel
- Antimicrobial Resistance and Genomic Characterization of OXA-48- and CTX-M-15-Co-Producing Hypervirulent Klebsiella pneumoniae ST23 Recovered from Nosocomial Outbreak
- (2020) Elvira Shaidullina et al. Antibiotics-Basel
- Rationalizing antimicrobial therapy in the ICU: a narrative review
- (2019) Jean-François Timsit et al. INTENSIVE CARE MEDICINE
- Activity of ceftolozane-tazobactam against Pseudomonas aeruginosa and Enterobacterales isolates recovered in Intensive Care Units in Spain: The SUPERIOR multicentre study
- (2019) Sergio García-Fernández et al. INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS
- Plasmid evolution in carbapenemase‐producing Enterobacteriaceae : a review
- (2019) Katlego Kopotsa et al. Annals of the New York Academy of Sciences
- Sequence-Based Epidemiology of an OXA-48 Plasmid during a Hospital Outbreak
- (2019) Laura Hidalgo et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- The Global Ascendency of OXA-48-Type Carbapenemases
- (2019) Johann D. D. Pitout et al. CLINICAL MICROBIOLOGY REVIEWS
- The difficulties of identifying and treating Enterobacterales with OXA-48-like carbapenemases
- (2019) J.M. Kidd et al. CLINICAL MICROBIOLOGY AND INFECTION
- Diversity of carbapenemase-producing Escherichia coli isolates, France 2012-2013
- (2018) Lauraine Gauthier et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Genetic and Biochemical characterization of OXA-519, a novel OXA-48-like β-lactamase
- (2018) Laura Dabos et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Carbapenemase-producing Enterobacteriaceae in Mexico: report of seven non-clonal cases in a pediatric hospital
- (2018) Alejandra Aquino-Andrade et al. BMC MICROBIOLOGY
- Treatment of Infections Caused by Extended-Spectrum-Beta-Lactamase-, AmpC-, and Carbapenemase-Producing Enterobacteriaceae
- (2018) Jesús Rodríguez-Baño et al. CLINICAL MICROBIOLOGY REVIEWS
- Widespread increase of empirical carbapenem use in acute care hospitals in Catalonia, Spain
- (2018) Santiago Grau et al. ENFERMEDADES INFECCIOSAS Y MICROBIOLOGIA CLINICA
- Molecular characterization of OXA-48 carbapenemase-producing Klebsiella pneumoniae strains after a carbapenem resistance increase in Catalonia
- (2018) Marc Argente et al. ENFERMEDADES INFECCIOSAS Y MICROBIOLOGIA CLINICA
- Management of infections caused by extended-spectrum β–lactamase-producing Enterobacteriaceae: current evidence and future prospects
- (2018) Chau-Chyun Sheu et al. Expert Review of Anti-Infective Therapy
- In vitro activity of imipenem/relebactam against Gram-negative ESKAPE pathogens isolated in 17 European countries: 2015 SMART surveillance programme
- (2018) James A Karlowsky et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- A multiplex lateral flow immunoassay for the rapid identification of NDM-, KPC-, IMP- and VIM-type and OXA-48-like carbapenemase-producing Enterobacteriaceae
- (2018) Hervé Boutal et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- Geographical and temporal clustering of OXA-48-producing Escherichia coli ST410 causing community-onset urinary tract infection in Christchurch, New Zealand
- (2018) J C Howard et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- OUP accepted manuscript
- (2018) JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- Epidemic spread of OXA-48 beta-lactamase in Croatia
- (2018) Branka Bedenić et al. JOURNAL OF MEDICAL MICROBIOLOGY
- A Long-Term Study of the Diversity of OXA-48-Like Carbapenemase-Producing Bacterial Strains in Infected Patients and Carriers
- (2018) Paul-Louis Woerther et al. Microbial Drug Resistance
- Treatment of Infections with OXA-48 producing Enterobacteriaceae
- (2018) Adam Stewart et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- First report of an OXA-48 and CTX-M-213-producing Kluyvera spp. clone recovered from patients admitted in a University Hospital in Madrid, Spain
- (2018) Marta Hernández-García et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Genetic and Biochemical Characterization of OXA-535, a Distantly Related OXA-48-Like β-Lactamase
- (2018) L. Dabos et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Optimizing therapy in CRE infections
- (2018) Mario Tumbarello et al. CURRENT OPINION IN INFECTIOUS DISEASES
- Sink traps as the source of transmission of OXA-48–producing Serratia marcescens in an intensive care unit
- (2018) Gili Regev-Yochay et al. INFECTION CONTROL AND HOSPITAL EPIDEMIOLOGY
- Risk factors for colonization by carbapenemase-producing enterobacteria at admission to a Surgical ICU: A retrospective study
- (2017) Emilio Maseda et al. ENFERMEDADES INFECCIOSAS Y MICROBIOLOGIA CLINICA
- OXA-48-like carbapenemases producing Enterobacteriaceae in different niches
- (2017) Assia Mairi et al. EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES
- OXA-48-like carbapenemases in the UK: an analysis of isolates and cases from 2007 to 2014
- (2017) Jacqueline Findlay et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- In Vitro Activity of Imipenem against Carbapenemase-Positive Enterobacteriaceae Isolates Collected by the SMART Global Surveillance Program from 2008 to 2014
- (2017) James A. Karlowsky et al. JOURNAL OF CLINICAL MICROBIOLOGY
- Beta-lactamase database (BLDB) – structure and function
- (2017) Thierry Naas et al. JOURNAL OF ENZYME INHIBITION AND MEDICINAL CHEMISTRY
- Occurrence of carbapenemase-producing Klebsiella pneumoniae and Escherichia coli in the European survey of carbapenemase-producing Enterobacteriaceae (EuSCAPE): a prospective, multinational study
- (2017) Hajo Grundmann et al. LANCET INFECTIOUS DISEASES
- Infection prevention and control measures and tools for the prevention of entry of carbapenem-resistant Enterobacteriaceae into healthcare settings: guidance from the European Centre for Disease Prevention and Control
- (2017) A. P. Magiorakos et al. Antimicrobial Resistance and Infection Control
- Results from the Canadian Nosocomial Infection Surveillance Program on Carbapenemase-ProducingEnterobacteriaceae, 2010 to 2014
- (2016) Laura F. Mataseje et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- In VitroSusceptibility to Ceftazidime-Avibactam of Carbapenem-Nonsusceptible Enterobacteriaceae Isolates Collected during the INFORM Global Surveillance Study (2012 to 2014)
- (2016) Boudewijn L. M. de Jonge et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Molecular characterization of OXA-48-like-producing Enterobacteriaceae in the Czech Republic: evidence for horizontal transfer of pOXA-48-like plasmids
- (2016) Anna Skálová et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Risk factors for fecal carriage of carbapenemase producing Enterobacteriaceae among intensive care unit patients from a tertiary care center in India
- (2016) Gajanand Mittal et al. BMC MICROBIOLOGY
- Treatment options for extended-spectrum beta-lactamase (ESBL) and AmpC-producing bacteria
- (2016) Ryan G. D’Angelo et al. EXPERT OPINION ON PHARMACOTHERAPY
- Genome-based phylogeny and taxonomy of the ‘Enterobacteriales’: proposal for Enterobacterales ord. nov. divided into the families Enterobacteriaceae, Erwiniaceae fam. nov., Pectobacteriaceae fam. nov., Yersiniaceae fam. nov., Hafniaceae fam. nov., Morganellaceae fam. nov., and Budviciaceae fam. nov.
- (2016) INTERNATIONAL JOURNAL OF SYSTEMATIC AND EVOLUTIONARY MICROBIOLOGY
- Prevalence and risk factors for carriage of ESBL-producing Enterobacteriaceae in Amsterdam
- (2016) E. A. Reuland et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- Genetic and Biochemical Characterization of OXA-405, an OXA-48-Type Extended-Spectrum β-Lactamase without Significant Carbapenemase Activity
- (2015) Laurent Dortet et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- First Report of an OXA-48-Producing Multidrug-Resistant Proteus mirabilis Strain from Gaza, Palestine
- (2015) Liang Chen et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Prospective Multicenter Study of Carbapenemase-Producing Enterobacteriaceae from 83 Hospitals in Spain Reveals HighIn VitroSusceptibility to Colistin and Meropenem
- (2015) Jesús Oteo et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Intestinal carriage of Shewanella xiamenensis simulating carriage of OXA-48–producing Enterobacteriaceae
- (2015) Alberto Antonelli et al. DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE
- Rapid Detection of KPC, NDM, and OXA-48-Like Carbapenemases by Real-Time PCR from Rectal Swab Surveillance Samples
- (2015) Tracy D. Lee et al. JOURNAL OF CLINICAL MICROBIOLOGY
- Prevalence and Characterization of Carbapenem-Resistant Enterobacteriaceae Isolated from Mulago National Referral Hospital, Uganda
- (2015) Deogratius Okoche et al. PLoS One
- Detection of OXA-370, an OXA-48-Related Class D β-Lactamase, in Enterobacter hormaechei from Brazil
- (2014) Jorge L. M. Sampaio et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- OXA-48 Carbapenemase-Producing Salmonella enterica Serovar Kentucky Isolate of Sequence Type 198 in a Patient Transferred from Libya to Switzerland
- (2014) Salome N. Seiffert et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- OXA -Lactamases
- (2014) B. A. Evans et al. CLINICAL MICROBIOLOGY REVIEWS
- Carbapenemases in Enterobacteriaceae: Types and molecular epidemiology
- (2014) Luis Martínez-Martínez et al. ENFERMEDADES INFECCIOSAS Y MICROBIOLOGIA CLINICA
- Acquisition of carbapenemase-producing Enterobacteriaceae by healthy travellers to India, France, February 2012 to March 2013
- (2014) E Ruppé et al. Eurosurveillance
- Carbapenemase and virulence factors of Enterobacteriaceae in North Lebanon between 2008 and 2012: evolution via endemic spread of OXA-48
- (2014) R. Beyrouthy et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- Carbapenemase-Producing Enterobacteriaceae in Spain in 2012
- (2013) Jesús Oteo et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Intrapatient emergence of OXA-247: a novel carbapenemase found in a patient previously infected with OXA-163-producing Klebsiella pneumoniae
- (2013) S. Gomez et al. CLINICAL MICROBIOLOGY AND INFECTION
- In vitro activity of fosfomycin in combination with imipenem, meropenem, colistin and tigecycline against OXA 48–positive Klebsiella pneumoniae strains
- (2013) Ebru Evren et al. DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE
- Genetic and biochemical characterisation of OXA-232, a carbapenem-hydrolysing class D β-lactamase from Enterobacteriaceae
- (2013) Anaïs Potron et al. INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS
- Activity of MK-7655 combined with imipenem against Enterobacteriaceae and Pseudomonas aeruginosa
- (2013) D. M. Livermore et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- Detection of OXA-48-like Carbapenemase-Producing Klebsiella pneumoniae in a Tertiary Care Center in Turkey: Molecular Characterization and Epidemiology
- (2013) Ozlem Azap et al. Balkan Medical Journal
- Characterization of OXA-204, a Carbapenem-Hydrolyzing Class D β-Lactamase from Klebsiella pneumoniae
- (2012) Anaïs Potron et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Surveillance and Molecular Epidemiology of Klebsiella pneumoniae Isolates That Produce Carbapenemases: First Report of OXA-48-Like Enzymes in North America
- (2012) Christine Lascols et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Importation of OXA-48-producing Klebsiella pneumoniae from Kuwait
- (2012) L. Poirel et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- Emergence of OXA-48-producing Klebsiella pneumoniae and the novel carbapenemases OXA-244 and OXA-245 in Spain
- (2012) J. Oteo et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- OXA-48-like carbapenemases: the phantom menace
- (2012) L. Poirel et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- OXA-162, a novel variant of OXA-48 displays extended hydrolytic activity towards imipenem, meropenem and doripenem
- (2012) Murat Kasap et al. JOURNAL OF ENZYME INHIBITION AND MEDICINAL CHEMISTRY
- Discovery of blaOXA-199, a Chromosome-Based blaOXA-48-Like Variant, in Shewanella xiamenensis
- (2012) Zhiyong Zong PLoS One
- Carbapenem resistance in Enterobacteriaceae: here is the storm!
- (2012) Patrice Nordmann et al. TRENDS IN MOLECULAR MEDICINE
- Characterization of OXA-181, a Carbapenem-Hydrolyzing Class D β-Lactamase from Klebsiella pneumoniae
- (2011) Anaïs Potron et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- OXA-163, an OXA-48-Related Class D β-Lactamase with Extended Activity Toward Expanded-Spectrum Cephalosporins
- (2011) Laurent Poirel et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Plasmid-mediated carbapenem-hydrolysing OXA-48 β-lactamase in Klebsiella pneumoniae from Tunisia
- (2010) Gaelle Cuzon et al. INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS
- Updated Functional Classification of -Lactamases
- (2009) K. Bush et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Plasmid-Encoded Carbapenem-Hydrolyzing -Lactamase OXA-48 in an Imipenem-Susceptible Klebsiella pneumoniae Strain from Belgium
- (2008) G. Cuzon et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Spread of OXA-48-Positive Carbapenem-Resistant Klebsiella pneumoniae Isolates in Istanbul, Turkey
- (2008) A. Carrer et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- The growing burden of antimicrobial resistance
- (2008) P. M. Hawkey JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now